Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT03419936
Other study ID # 2015-0823
Secondary ID
Status Recruiting
Phase N/A
First received January 27, 2018
Last updated January 27, 2018
Start date March 21, 2016
Est. completion date March 21, 2020

Study information

Verified date January 2018
Source Asan Medical Center
Contact myungeun Lee, BA
Phone +82-2-3010-7190
Email lme23@amc.seoul.kr
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

The purpose of this study is to know the distribution of Helicobacter pylori in stomach before subtotal gastrectomy and after subtotal gastrectomy.


Description:

Endoscopy and biopsy will be performed to investigate the distribution of Helicobacter pylori before and after subtotal gastrectomy.


Recruitment information / eligibility

Status Recruiting
Enrollment 60
Est. completion date March 21, 2020
Est. primary completion date March 21, 2020
Accepts healthy volunteers No
Gender All
Age group 19 Years to 75 Years
Eligibility Inclusion Criteria:

1. Patients who are indicated to subtotal gastrectomy due to gastric neoplasm

2. Aged between 19 to 75 years

3. Informed consent

Exclusion Criteria:

1. Previous history of Helicobacter pylori eradication

2. Previous history of proton pump inhibitor use within 6 months

Study Design


Intervention

Diagnostic Test:
Endoscopic biopsy
Pre-operation (initial diagnosis) Assessment atrophy and metaplasia in stomach, Check Helicobacter pylori Post-subtotal gastrectomy (After 6 months) Assess the distribution of helicobacter pylori after subtotal gastrectomy. Post-subtotal gastrectomy (After 12 months) Assess the distribution of helicobacter pylori after subtotal gastrectomy. Post-subtotal gastrectomy (After 24 months) Assess the distribution of helicobacter pylori after subtotal gastrectomy.

Locations

Country Name City State
Korea, Republic of Asan Medical Center Seoul Songpa-gu

Sponsors (1)

Lead Sponsor Collaborator
Asan Medical Center

Country where clinical trial is conducted

Korea, Republic of, 

Outcome

Type Measure Description Time frame Safety issue
Primary Distribution of Helicobacter Pylori After Gastrectomy Analysis the change of Helicobacter pylori according to the subtotal gastrectomy Change in the distribution of Helicobacter Pylori at 2 years
Secondary Change of atrophy after gastrectomy Analysis the change of atrophic status according to the subtotal gastrectomy Change in the atrophic status at 2 years
See also
  Status Clinical Trial Phase
Recruiting NCT02123771 - Gamma-Glutamyl Transpeptidase (GGT): A Potential Diagnostic Marker for Helicobacter Pylori Infections Phase 1
Recruiting NCT02047994 - Multicentric Randomized Study of H. Pylori Eradication and Pepsinogen Testing for Prevention of Gastric Cancer Mortality Phase 4